Medtronic vs ALSAC

XRlabs Raises €7.48M for AI Surgical Intelligence

London-based XRlabs, a Surgical Intelligence company founded by neurosurgeon Dr. Ali Haddad, has raised €7.48 million ($8.4 million) in Seed funding. The round was led by Playground Global (Palo Alto), with participation from London-based HealthTech investor Eka Ventures. The company develops modular, device-agnostic software that uses computer vision and deep learning to transform live surgical video, navigation telemetry, and pre-operative imaging into a real-time, anatomy-aware view. Its platform has been deployed in over 100 surgical cases across three continents. The funding will support engineering and clinical team expansion, regulatory advancement in the UK, EU, and US, and the extension of clinical evidence. XRlabs also announced Omar Ishrak, former CEO of Medtronic, as Chair of its Board. The company has been awarded compute allocation on the UK AI Research Resource (AIRR).

• XRlabs raised €7.48 million ($8.4 million) in Seed funding led by Playground Global with participation from Eka Ventures.
• Omar Ishrak, former CEO of Medtronic, joined as Chair of XRlabs' Board of Directors.
• The company's platform has been deployed in over 100 surgical cases on three continents.

8-K Financial Filing Analysis for Medtronic (2026-09-01)

On September 1, 2026, Medtronic plc filed a Form 8-K under Item 2.02 (Results of Operations and Financial Condition) announcing its financial results for the first quarter of fiscal year 2027. The details of the quarterly performance were furnished via press release in Exhibit 99.1, signed by Executive Vice President and Chief Financial Officer Thierry Piéton.

• Medtronic plc furnished its Q1 FY2027 financial results via Form 8-K on September 1, 2026.
• The earnings announcement is furnished under Item 2.02 with details provided in Exhibit 99.1.
• The filing was formally authorized and signed by Executive Vice President and CFO Thierry Piéton.

Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc.

Medtronic plc (Medtronic; NYSE: MDT) today announced the final exchange ratio for its previously announced offer to exchange outstanding Medtronic ordinary shares for shares of common stock of MiniMed Group, Inc.

St. Jude Newsroom: KDM2B revealed as a selective dependency in high-risk medulloblastoma subgroups

The St. Jude Newsroom page has been updated with several new press releases. Notable additions include: 'KDM2B revealed as a selective dependency in high-risk medulloblastoma subgroups' (09/24/2026), 'Targeting ZMYND8 improves T-cell function and may boost immunotherapy' (09/23/2026), 'U.S. News & World Report ranks St. Jude among top three outstanding pediatric cancer hospitals' (09/15/2026), 'AI-informed AdaptiveFlow redefines large-scale cloud computing for drug discovery' (09/01/2026), 'ALSAC Named to Fast Company's 2026 Best Workplaces for Innovators List' (09/10/2026), and 'Chili's® Announces Historic $150 Million Commitment to St. Jude Children's Research Hospital®' (09/08/2026).

Chili’s® Announces Historic $150 Million Commitment to St. Jude Children’s Research Hospital®

Chili’s® Grill & Bar made a new pledge to help raise $150 million over the next 15 years to help support children and families facing cancer and other life-threatening diseases at St. Jude.